Novartis Pharma Acquires Exclusive Rights From Vanda Pharmaceuticals for Commercialization of Fanapt(TM) in the United States and Canada October 13, 2009
Titan Announces FDA Approval of Fanapt(TM) (Iloperidone) For the Treatment of Schizophrenia May 7, 2009
